A citation-based method for searching scientific literature

Włodzimierz Łuczyński, Barbara Głowińska-Olszewska, Artur Bossowski. Diabetes Metab Res Rev 2016
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States.
Stephanie N DuBose, Julia M Hermann, William V Tamborlane, Roy W Beck, Axel Dost, Linda A DiMeglio, Karl Otfried Schwab, Reinhard W Holl, Sabine E Hofer, David M Maahs. J Pediatr 2015
97
66

Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.
Diane K Wherrett, Jane L Chiang, Alan M Delamater, Linda A DiMeglio, Stephen E Gitelman, Peter A Gottlieb, Kevan C Herold, Daniel J Lovell, Trevor J Orchard, Christopher M Ryan,[...]. Diabetes Care 2015
50
33

Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.
Kristen J Nadeau, Kelsey Chow, Suhyla Alam, Kara Lindquist, Sarah Campbell, Kim McFann, Georgeanna Klingensmith, Phillipe Walravens. Pediatr Diabetes 2015
46
33

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, Kevan C Herold, Lisa D Jansa, Hubert Kolb, John M Lachin, Kenneth S Polonsky, Paolo Pozzilli, Jay S Skyler,[...]. Diabetes 2004
323
33


Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
Wei Hao, Steven Gitelman, Linda A DiMeglio, David Boulware, Carla J Greenbaum. Diabetes Care 2016
67
33

Treatment of diabetes in children.
Yi-Qing Gao, Min Gao, Ying Xue. Exp Ther Med 2016
5
33

Gut peptide hormones and pediatric type 1 diabetes mellitus.
M Huml, J Kobr, K Siala, J Varvařovská, R Pomahačová, M Karlíková, J Sýkora. Physiol Res 2011
26
33

Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus.
Tatsuhiko Urakami, Shigeo Morimoto, Misao Owada, Kensuke Harada. Pediatr Int 2005
20
33

Continuous rise of insulin resistance before and after the onset of puberty in children at increased risk for type 1 diabetes - a cross-sectional analysis.
Jennifer Raab, Florian Haupt, Olga Kordonouri, Marlon Scholz, Anja Wosch, Christiane Ried, Bärbel Aschemeier, Thomas Danne, Anette-G Ziegler, Christiane Winkler. Diabetes Metab Res Rev 2013
14
33

Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study.
Aaron S Kelly, Andrea M Metzig, Kyle D Rudser, Angela K Fitch, Claudia K Fox, Brandon M Nathan, Mary M Deering, Betsy L Schwartz, M Jennifer Abuzzahab, Laura M Gandrud,[...]. Obesity (Silver Spring) 2012
72
33

Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats.
Atsuo Tahara, Eiji Kurosaki, Masanori Yokono, Daisuke Yamajuku, Rumi Kihara, Yuka Hayashizaki, Toshiyuki Takasu, Masakazu Imamura, Qun Li, Hiroshi Tomiyama,[...]. J Pharm Pharmacol 2014
72
33


The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.
David Zi Cherney, Bruce A Perkins, Nima Soleymanlou, Ronnie Har, Nora Fagan, Odd Erik Johansen, Hans-Juergen Woerle, Maximilian von Eynatten, Uli C Broedl. Cardiovasc Diabetol 2014
305
33

Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
David J Klein, Tadej Battelino, D J Chatterjee, Lisbeth V Jacobsen, Paula M Hale, Silva Arslanian. Diabetes Technol Ther 2014
47
33

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
T Vilsbøll, T Krarup, J Sonne, S Madsbad, A Vølund, A G Juul, J J Holst. J Clin Endocrinol Metab 2003
365
33

Insulin sensitivity in Type 1 diabetic children and adolescents.
A Szadkowska, I Pietrzak, B Mianowska, J Bodalska-Lipińska, H A Keenan, E Toporowska-Kowalska, W Młynarski, J Bodalski. Diabet Med 2008
50
33

Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.
Pablo Lapuerta, Brian Zambrowicz, Paul Strumph, Arthur Sands. Diab Vasc Dis Res 2015
69
33

Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes.
Torben Biester, Baerbel Aschemeier, Maryam Fath, Marcel Frey, Markus F Scheerer, Olga Kordonouri, Thomas Danne. Diabetes Obes Metab 2017
19
33

Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.
Bruce A Perkins, David Z I Cherney, Helen Partridge, Nima Soleymanlou, Holly Tschirhart, Bernard Zinman, Nora M Fagan, Stefan Kaspers, Hans-Juergen Woerle, Uli C Broedl,[...]. Diabetes Care 2014
166
33

Demographic and clinical correlates of diabetes-related quality of life among youth with type 1 diabetes.
Jean M Lawrence, Joyce P Yi-Frazier, Mary Helen Black, Andrea Anderson, Korey Hood, Giuseppina Imperatore, Georgeanna J Klingensmith, Michelle Naughton, Elizabeth J Mayer-Davis, Michael Seid. J Pediatr 2012
82
33


Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial.
Jemma Anderson, Alexia S Peña, Thomas Sullivan, Roger Gent, Bronwen D'Arcy, Timothy Olds, Brian Coppin, Jennifer Couper. BMC Pediatr 2013
17
33

A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8).
Paolo Pozzilli, Antonino Crinò, Riccardo Schiaffini, Silvia Manfrini, Elvira Fioriti, Giusy Coppolino, Dario Pitocco, Natalia Visalli, Stefania Corbi, Sabrina Spera,[...]. Diabetes Technol Ther 2003
19
33

Double diabetes: a mixture of type 1 and type 2 diabetes in youth.
Paolo Pozzilli, Chiara Guglielmi. Endocr Dev 2009
30
33

Advances in management of type 1 diabetes mellitus.
Ravindranath Aathira, Vandana Jain. World J Diabetes 2014
27
33

The past, present, and future of basal insulins.
Jeremy Pettus, Tricia Santos Cavaiola, William V Tamborlane, Steven Edelman. Diabetes Metab Res Rev 2016
43
33


Use of metformin in pediatric age.
Claudia Brufani, Danilo Fintini, Valerio Nobili, Patrizia Ippolita Patera, Marco Cappa, Mario Brufani. Pediatr Diabetes 2011
23
33

Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.
D Pitocco, F Zaccardi, P Tarzia, M Milo, G Scavone, P Rizzo, F Pagliaccia, R Nerla, A Di Franco, A Manto,[...]. Diabetes Obes Metab 2013
44
33

Pharmacological Properties of Faster-Acting Insulin Aspart.
Torben Biester, Olga Kordonouri, Thomas Danne. Curr Diab Rep 2017
10
33

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
Arthur T Sands, Brian P Zambrowicz, Julio Rosenstock, Pablo Lapuerta, Bruce W Bode, Satish K Garg, John B Buse, Phillip Banks, Rubina Heptulla, Marc Rendell,[...]. Diabetes Care 2015
125
33

New potential adjuncts to treatment of children with type 1 diabetes mellitus.
Vandana S Raman, Rubina A Heptulla. Pediatr Res 2009
13
33

Challenges in developing endpoints for type 1 diabetes intervention studies.
Simona Cernea, Itamar Raz, Kevan C Herold, Boaz Hirshberg, Bart O Roep, Desmond A Schatz, G Alexander Fleming, Paolo Pozzilli, Randie Little, Nanette C Schloot,[...]. Diabetes Metab Res Rev 2009
12
33

Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study.
Michelle J Naughton, Andrea M Ruggiero, Jean M Lawrence, Giuseppina Imperatore, Georgeanna J Klingensmith, Beth Waitzfelder, Robert E McKeown, Debra A Standiford, Angela D Liese, Beth Loots. Arch Pediatr Adolesc Med 2008
84
33


Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
A Barker, A Lauria, N Schloot, N Hosszufalusi, J Ludvigsson, C Mathieu, D Mauricio, M Nordwall, B Van der Schueren, T Mandrup-Poulsen,[...]. Diabetes Obes Metab 2014
54
33

Glucose toxicity.
L Rossetti, A Giaccari, R A DeFronzo. Diabetes Care 1990
787
33

Potential adjunctive therapies in adolescents with type 1 diabetes mellitus.
Craig A Jefferies, Jill Hamilton, Denis Daneman. Treat Endocrinol 2004
7
33

The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.
Sam Tsz Wai Cheng, Lihua Chen, Stephen Yu Ting Li, Eric Mayoux, Po Sing Leung. PLoS One 2016
44
33

BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children.
A Lauria, A Barker, N Schloot, N Hosszufalusi, J Ludvigsson, C Mathieu, D Mauricio, M Nordwall, B Van der Schueren, T Mandrup-Poulsen,[...]. Eur J Endocrinol 2015
30
33

Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries.
Sarah K Lyons, Julia M Hermann, Kellee M Miller, Sabine E Hofer, Nicole C Foster, Birgit M Rami-Merhar, Grazia Aleppo, Jochen Seufert, Linda A DiMeglio, Thomas Danne,[...]. Diabetes Care 2017
30
33

Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes.
Elizabeth M Lamos, Lisa M Younk, Stephen N Davis. Expert Opin Investig Drugs 2014
28
33

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.
Venkat Sasidhar Renukuntla, Neesha Ramchandani, Jeniece Trast, Martin Cantwell, Rubina A Heptulla. J Diabetes Sci Technol 2014
32
33

Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.
Mark D DeBoer, Marc D Breton, Christian Wakeman, Elaine M Schertz, Emma G Emory, Jessica L Robic, Laura L Kollar, Boris P Kovatchev, Daniel R Cherñavvsky. Diabetes Technol Ther 2017
23
33



Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
273
33

An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide.
Birgitte Damholt, Georg Golor, Werner Wierich, Poul Pedersen, Marianne Ekblom, Milan Zdravkovic. J Clin Pharmacol 2006
46
33

Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
Robert R Henry, Julio Rosenstock, Steven Edelman, Sunder Mudaliar, Alexandros-Georgios Chalamandaris, Sreeneeranj Kasichayanula, Allyson Bogle, Nayyar Iqbal, James List, Steven C Griffen. Diabetes Care 2015
151
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.